Literature DB >> 3687778

Guidelines for the interpretation of the exercise radionuclide ventriculogram for diagnosing coronary artery disease.

I P Clements1, R J Gibbons, H T Mankin, A R Zinsmeister, M L Brown.   

Abstract

In 622 patients with known coronary artery anatomy, heart rate (HR).blood pressure (BP) product and left ventricular (LV) ejection fraction (EF) at maximal supine exercise measured by radionuclide ventriculography were used to estimate, by logistic regression analysis, the probabilities of absence of significant coronary artery disease (CAD), presence of significant CAD, presence of multivessel CAD and presence of 3-vessel CAD. Thus, for example, estimated probabilities of each of the aforementioned 4 categories of CAD are 0.39, 0.61, 0.32 and 0.12, respectively, for HR.BP product of 26,000 beats.mm Hg/min and LVEF of 0.6 at maximal exercise and 0.08, 0.92, 0.77 and 0.48, respectively, for HR.BP of 15,000 and LVEF of 0.4. The graphic presentations of these estimated probabilities form useful guidelines for interpreting the results of exercise radionuclide ventriculography. In addition, specific cutoff values at maximal exercise defined 2 groups: (HR.BP product greater than or equal to 21,000 beats.mm Hg/min and LVEF greater than or equal to 0.55) with a high (70%) likelihood of absence of significant CAD or 1-vessel CAD and a low (7%) likelihood of 3-vessel CAD, and (HR.BP product less than 21,000 and LVEF less than 0.55) with a high (72%) likelihood of multivessel CAD and a low (8%) likelihood of absence of CAD.

Entities:  

Mesh:

Year:  1987        PMID: 3687778     DOI: 10.1016/0002-9149(87)90605-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Identification of exercise-induced left ventricular systolic and diastolic dysfunction using gated SPECT in patients with coronary artery disease.

Authors:  Kenzo Sakamoto; Tomoki Nakamura; Kan Zen; Takato Hikosaka; Takeshi Nakamura; Tetsuhiro Yamano; Takahisa Sawada; Akihiro Azuma; Hitoshi Yaku; Hiroki Sugihara; Tsunehiko Nishimura; Masao Nakagawa
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.